ArsenalBio Stock
ArsenalBio is building a programmable cell therapy company to create highly effective and accessible immune cell therapies to impact outcomes for a much broader number of patients, initially those with cancer. ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies. With its programmable and computationally driven approach, ArsenalBio aspires to evolve critical metrics of success for immune cell therapies, including enhanced and broader efficacy, increased patient safety, reduced provider costs, and expanded market access.
Sign up for SecondMarket™ to view the market and buy or sell ArsenalBio Stock
Buy + SellArsenalBio Funding
Sign up to gain insights into ArsenalBio funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Jul 09, 2024 | Series C | 297.50M | ||
| May 31, 2022 | Series B | 88.81M | ||
| Feb 10, 2022 | Series B | 99.00M | ||
| Dec 14, 2020 | Series B | 33.00M | ||
| Oct 17, 2019 | Series A | 85.00M |
See ArsenalBio Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into ArsenalBio Stock Valuation + Share Prices
View real-time Tape D™ data on ArsenalBio stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
ArsenalBio Management Team
Director
Matthew K. Fust
Director
Brook Byers
Chief Technology Officer
Tarjei Mikkelsen
Chief People Officer
Bee Nguyen
Co-Founder, CEO, Chairman
Ken Drazan
Director
Sean Parker
Director
Valentin Barsan
Director
Beth Seidenberg
Chief Scientific Officer
W. Nicholas Haining
Chief Medical Officer
Susie Jun
Chief Technical Operations Officer
Tim Sirichoke
ArsenalBio Major Investors
The Parker Institute for Cancer Immunotherapy
Westlake Village BioPartners
Osage Partners LLC
Euclidean Capital
UCSF Foundation Investment Company
Sixth Street Partners
Waycross Ventures
Bristol-Myers Squibb Company
Hitachi America, Ltd.
Byers Capital
Green Sands Equity
Kleiner Perkins Caufield & Byers LLC (KPCB)
Softbank Vision Fund 2
Emerson Collective LLC
Learn More About ArsenalBio Stock
Buy ArsenalBio Stock
01ArsenalBio stock does not trade on public stock exchanges. ArsenalBio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ArsenalBio stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell ArsenalBio Stock
02ArsenalBio Stock does not trade on public stock exchanges. In order to sell ArsenalBio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ArsenalBio Stock Price
03ArsenalBio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view ArsenalBio share price and other valuable private market data.
Read more about secondary market private company stock prices:
ArsenalBio Stock Ticker Symbol
04There is no ticker symbol for ArsenalBio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell ArsenalBio Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ArsenalBio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in ArsenalBio Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ArsenalBio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
ArsenalBio Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ArsenalBio IPO
08ArsenalBio is a private company and has not had an IPO. There is currently no ArsenalBio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to ArsenalBio IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell ArsenalBio Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
